Pharma Stock Roundup: FDA Nod to MRKs New Jab & Expanded Use of ABBV & AZN Drugs
FDA approves Mercks (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVies (ABBV) Skyrizi and AstraZenecas (AZN)…
77,250€
-0,96%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Global Anal Fissure Treatment Market Size To Exceed USD 1986.1 Million By 2033 | CAGR Of 5.51%
The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…
Trading in Trill Impact’s portfolio company Cinclus Pharma commences on Nasdaq Stockholm
The Swedish biopharmaceutical company has successfully raised capital for Phase 3 clinical development
Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) is…
AstraZenecas (AZN) Truqap Gets EU Nod for Breast Cancer
The European Commission approves AstraZenecas (AZN) Truqap in combination with Faslodex for ER-positive, HER2-negative advanced or metastatic breast cancer.…
AstraZenecas (AZN) Truqap Misses Endpoints in TNBC Study
AstraZenecas (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients with locally advanced/metastatic triple-negative breast cancer fails to…